|19.13|| +0.33 / +1.76%|
Meridian Bioscience, Inc. is a fully integrated life science company. The company develops, markets and distributes diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. It operates through two segments: Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations in Cincinnati, Ohio and the sale and distribution of diagnostic test kits in the US, Europe, Africa and the Middle East. The Life Science operating segment consists of manufacturing operations in Memphis, Tennessee; Saco, Maine; Boca Raton, Florida; London, England; Luckenwalde, Germany; and Sydney, Australia and the sale and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells and bioresearch reagents domestically and abroad. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.
|John A. Kraeutler||Chairman, President & Chief Executive Officer|
|Lawrence J. Baldini||Executive VP-Operations & Information Systems|
|Melissa A. Lueke||Chief Financial Officer, Secretary, CAO & EVP|
|Vecheslav A. Elagin||Executive Vice President-Research & Development|
|Richard L. Eberly||Executive Vice President|